All lobbying filings

ALPINE GROUP PARTNERS, LLC.

Lobbying for GLAXOSMITHKLINE LLC · pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 3

Medicare/Medicaid

Issues related to prescription drug pricing Issues related to Pharmacy Benefit Managers

Budget/Appropriations

FY26 DOD and HHS appropriations and medical research

Health Issues

Implementation of the Inflation Reduction Act (PL 117-169) Issues related to the reauthorization of the Pandemic All Hazards Preparedness Act Issues related to Pharmacy Benefit Managers Issues related to supply chains

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.